Ming Gao , Ninghua Li , Hui Wang , Weiqin Li , Tao Zhang , Yijuan Qiao , Jing Li , Zhijie Yu , Gang Hu , Junhong Leng , David Simmons , Xilin Yang
{"title":"High fasting plasma glucose in early pregnancy and increased risk of adverse pregnancy outcomes in Chinese women: the role of gestational age","authors":"Ming Gao , Ninghua Li , Hui Wang , Weiqin Li , Tao Zhang , Yijuan Qiao , Jing Li , Zhijie Yu , Gang Hu , Junhong Leng , David Simmons , Xilin Yang","doi":"10.1016/j.diabres.2025.112126","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>To identify any cut-off point to define hyperglycemia and optimal gestational time for hyperglycemia screening in early pregnancy.</div></div><div><h3>Methods</h3><div>A prospective cohort of 19,134 pregnant women was established in Tianjin, China. The primary outcome was a composite of pregnancy-induced hypertension, macrosomia, large for gestational age (LGA), preterm birth, perinatal death and Apgar score at 1 min < 7. Restricted cubic spline (RCS) was performed to test non-linear associations of fasting plasma glucose (FPG) and gestational age at FPG measurement with composite adverse pregnancy outcome (CAPO). Additive interactions were used to test different effects of FPGs on CAPO by gestational age in early pregnancy.</div></div><div><h3>Results</h3><div>FPG 5.1–6.9 mmol/L before 20 gestational weeks was associated with significantly increased risks of CAPO, macrosomia and LGA (adjusted ORs: 1.18, 95 %CIs: 1.09–1.29; 1.28, 1.15–1.44; 1.27, 1.15–1.41, respectively) with a discernible threshold. The risk associations persisted after excluding women diagnosed with gestational diabetes mellitus (GDM) at 24–28 gestational weeks. More importantly, FPG 5.1–6.9 mmol/L at 9–19 weeks but not before 9 weeks of gestation was associated with increased risk of CAPO, macrosomia and LGA, with significant additive interactions.</div></div><div><h3>Conclusions</h3><div>Early GDM could be defined as FPG 5.1–6.9 mmol/L at 9–19 gestational weeks among Chinese pregnant women.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"223 ","pages":"Article 112126"},"PeriodicalIF":6.1000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725001408","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Aims
To identify any cut-off point to define hyperglycemia and optimal gestational time for hyperglycemia screening in early pregnancy.
Methods
A prospective cohort of 19,134 pregnant women was established in Tianjin, China. The primary outcome was a composite of pregnancy-induced hypertension, macrosomia, large for gestational age (LGA), preterm birth, perinatal death and Apgar score at 1 min < 7. Restricted cubic spline (RCS) was performed to test non-linear associations of fasting plasma glucose (FPG) and gestational age at FPG measurement with composite adverse pregnancy outcome (CAPO). Additive interactions were used to test different effects of FPGs on CAPO by gestational age in early pregnancy.
Results
FPG 5.1–6.9 mmol/L before 20 gestational weeks was associated with significantly increased risks of CAPO, macrosomia and LGA (adjusted ORs: 1.18, 95 %CIs: 1.09–1.29; 1.28, 1.15–1.44; 1.27, 1.15–1.41, respectively) with a discernible threshold. The risk associations persisted after excluding women diagnosed with gestational diabetes mellitus (GDM) at 24–28 gestational weeks. More importantly, FPG 5.1–6.9 mmol/L at 9–19 weeks but not before 9 weeks of gestation was associated with increased risk of CAPO, macrosomia and LGA, with significant additive interactions.
Conclusions
Early GDM could be defined as FPG 5.1–6.9 mmol/L at 9–19 gestational weeks among Chinese pregnant women.
期刊介绍:
Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.